Fresh Equities
Raises
Research
About
Looking for more information?

Contact our responsive and friendly client services team any time.

(03) 9028 2888

clients@freshequities.com

Biotron Limited

INVESTOR PRESENTATION - Biotron Limited

ASX:BIT

Biotron Limited

Health

Biotron Limited (BIT) is a biotechnology company engaged in research, development, and commercialisation of drugs targeting viral diseases with unmet medical need. The Company focuses on the progression of the clinical development of the drug, BIT225, an investigational, orally-administered, novel antiviral compound in development by Biotron for treatment of HCV and HIV infections.

Read more

Market Cap

$56.15m

Price at Close

$0.08

4w avg. Volume

763.03k

4w avg. Turnover

$60.38k

Announcements
announcementt+2 movementdate
  • Results of Meeting

    Notice Of Meeting

  • +1.19%

    19 Nov 2020

+1.19%

19 Nov 2020
  • Presentation to Annual General Meeting

    Periodic Reports

  • +1.19%

    19 Nov 2020

+1.19%

19 Nov 2020
  • Quarterly Activities Report

    Commitments test entity quarterly reports · Market sensitive

  • +1.19%

    29 Oct 2020

+1.19%

29 Oct 2020
  • Quarterly Cashflow Report

    Commitments test entity quarterly reports · Market sensitive

  • +1.19%

    29 Oct 2020

+1.19%

29 Oct 2020
  • BIT225 HIV-1 Immunomodulatory Paper Published

    Progress Report

  • -1.04%

    14 Oct 2020

-1.04%

14 Oct 2020
  • Presentation to Investors

    Periodic Reports

  • -1.04%

    14 Oct 2020

-1.04%

14 Oct 2020
  • Annual Report and Notice of Annual General Meeting

    Periodic Reports

  • +2.22%

    08 Oct 2020

+2.22%

08 Oct 2020
  • Biotron Compounds Show Activity Against SARS-CoV-2 Virus

    Stock Exchange Announcement · Market sensitive

  • -4.55%

    06 Sep 2020

-4.55%

06 Sep 2020
  • Trading Halt

    Stock Exchange Announcement · Market sensitive

  • +15.79%

    03 Sep 2020

+15.79%

03 Sep 2020
  • Pause in Trading

    Stock Exchange Announcement · Market sensitive

  • +15.79%

    03 Sep 2020

+15.79%

03 Sep 2020
Market Data

Current Price

$0.08

52WK HIGH

$0.185

52WK LOW

$0.058

1YR RETURN

+31.15%

1YR RETURN VS. SECTOR

-6.37%

90 DAY RETURN

-12.09%

ASX RANK

1,114

/2,047

SECTOR RANK

98

/168

SHARES OUTSTANDING

701.93m
ASX:BIT

Biotron Limited

Health

Biotron Limited (BIT) is a biotechnology company engaged in research, development, and commercialisation of drugs targeting viral diseases with unmet medical need. The Company focuses on the progression of the clinical development of the drug, BIT225, an investigational, orally-administered, novel antiviral compound in development by Biotron for treatment of HCV and HIV infections.

Read more

Market Cap

$56.15m

Price at Close

$0.08

4w avg. Volume

763.03k

4w avg. Turnover

$60.38k

ASX:BIT is not raising right now

Want to invest?

Fresh Equities

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.

Contact Us

(03) 9028 2888

clients@freshequities.com

Address

Level 7, 388 Bourke St
Melbourne VIC 3000
Australia

Copyright © 2020 Fresh Equities. All rights reserved. ACN 619 657 028. CAR: 001267539 of AFSL: 471379.